ReviewDrug discovery today2018

A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.

Samaresh Sau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.